Prolonged suppression of human immunodeficiency virus type 1 RNA during dual nucleoside reverse-transcriptase-inhibitor therapy in clinical practice

Academic Article

Abstract

  • Because there is limited information about suppression of virus loads (determined by current "ultrasensitive" assays) in patients receiving nucleoside reverse-transcriptase inhibitors (NRTIs) alone, we reviewed our experience in clinical practice with patients who had virus loads of <25 copies/mL after >1 year of treatment with dual NRTIs.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Hoesley CJ; Saag MS; Chatham A; Kilby JM
  • Start Page

  • 1095
  • End Page

  • 1097
  • Volume

  • 31
  • Issue

  • 4